An Open-label, Randomized, Fasted, Single-dose, 2-sequence, 4-period, Replicate Crossover Study to Compare the Pharmacokinetic and Safety Between Administration of CKD-828 20/2.5mg and Administration of D064, D701 in Healthy Adults
Latest Information Update: 28 Aug 2023
At a glance
- Drugs D-064/D-701 (Primary) ; Levamlodipine/telmisartan (Primary)
- Indications Hypertension
- Focus Pharmacokinetics
- Sponsors Chong Kun Dang
Most Recent Events
- 24 Aug 2023 Status changed from not yet recruiting to completed.
- 02 May 2023 New trial record